Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

PCRX

Pacira BioSciences Inc

Jun 13 • 04:00PM ET

28.37

Dollar change -0.31
Percentage change -1.08	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: IJR CALF VTI IWM VB VXF VBK IJS SPSM IWO

Scroll to Statements

Index	RUT	P/E	20.37	EPS (ttm)	1.39	Insider Own	2.54%	Shs Outstand	46.48M	Perf Week	-2.58%
Market Cap	1.32B	Forward P/E	7.91	EPS next Y	3.58	Insider Trans	-9.17%	Shs Float	45.36M	Perf Month	-7.95%
Income	70.47M	PEG	2.10	EPS next Q	0.68	Inst Own	107.93%	Short Float	14.16%	Perf Quarter	-3.04%
Sales	681.75M	P/S	1.94	EPS this Y	-1.29%	Inst Trans	2.33%	Short Ratio	9.72	Perf Half Y	-1.08%
Book/sh	19.18	P/B	1.48	EPS next Y	29.22%	ROA	4.54%	Short Interest	6.43M	Perf Year	-23.24%
Cash/sh	7.00	P/C	4.05	EPS next 5Y	9.70%	ROE	8.49%	52W Range	25.33 - 41.65	Perf YTD	-15.92%
Dividend Est.	-	P/FCF	7.63	EPS past 5Y	-	ROI	4.84%	52W High	-31.88%	Beta	0.88
Dividend TTM	-	Quick Ratio	4.78	Sales past 5Y	15.46%	Gross Margin	64.74%	52W Low	12.00%	ATR (14)	1.14
Dividend Ex-Date	-	Current Ratio	5.81	EPS Y/Y TTM	780.50%	Oper. Margin	13.70%	RSI (14)	42.79	Volatility	3.97% 3.63%
Employees	712	Debt/Eq	0.65	Sales Y/Y TTM	1.88%	Profit Margin	10.34%	Recom	1.22	Target Price	43.56
Option/Short	Yes / Yes	LT Debt/Eq	0.63	EPS Q/Q	145.11%	Payout	0.00%	Rel Volume	1.11	Prev Close	28.68
Sales Surprise	1.09%	EPS Surprise	-0.02%	Sales Q/Q	4.23%	Earnings	May 07 AMC	Avg Volume	661.30K	Price	28.37
SMA20	-5.51%	SMA50	-0.47%	SMA200	-5.62%	Trades		Volume	736,237	Change	-1.08%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-07-24	Resumed	JP Morgan	Overweight	$80 → $45
Dec-20-23	Initiated	Raymond James	Outperform	$42
Aug-03-23	Upgrade	TD Cowen	Market Perform → Outperform	$50
Jan-31-23	Resumed	Wedbush	Outperform	$88 → $60
Oct-21-22	Resumed	Jefferies	Buy	$66
Jan-03-22	Resumed	JP Morgan	Overweight	$75 → $83
Jul-26-21	Upgrade	JP Morgan	Neutral → Overweight	$75
Apr-21-21	Resumed	JP Morgan	Neutral	$70
Apr-09-21	Initiated	Berenberg	Buy	$93
Apr-07-21	Resumed	RBC Capital Mkts	Outperform	$86
Feb-11-21	Downgrade	Northland Capital	Outperform → Market Perform	$72 → $75
Jan-21-21	Downgrade	SVB Leerink	Outperform → Mkt Perform	$75
Sep-21-20	Upgrade	Northland Capital	Market Perform → Outperform	$58 → $67
Jul-06-20	Reiterated	Needham	Buy	$52 → $64
May-27-20	Initiated	Guggenheim	Neutral
Apr-07-20	Initiated	Northland Capital	Outperform	$50
Mar-20-20	Upgrade	SVB Leerink	Mkt Perform → Outperform	$44
Feb-24-20	Reiterated	H.C. Wainwright	Buy	$60 → $63
Jan-24-20	Initiated	SunTrust	Buy
Jan-23-20	Initiated	SunTrust	Buy

Show Previous Ratings

Jun-06-24 11:31AM	Why Is Pacira (PCRX) Up 1.7% Since Last Earnings Report? (Zacks)
May-30-24 08:00AM	Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference (GlobeNewswire)
May-10-24 07:00AM	Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029 (GlobeNewswire)
May-08-24 04:05PM	Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes (GlobeNewswire) +11.84%
11:35AM	Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues (Zacks)
09:33AM	Loading…
09:33AM	Pacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:47AM	Pacira BioSciences Inc (PCRX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth ... (GuruFocus.com)
May-07-24 09:01PM	PCRX Stock Earnings: Pacira BioSciences Meets EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:03PM	Pacira BioSciences Reports Q1 2024 Results: Aligns with EPS Projections and Announces $150 ... (GuruFocus.com)
05:30PM	Here's What Key Metrics Tell Us About Pacira (PCRX) Q1 Earnings (Zacks)
04:13PM	Pacira: Q1 Earnings Snapshot (Associated Press Finance)
04:00PM	Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program (GlobeNewswire)
08:00AM	Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
Apr-30-24 08:00AM	Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024 (GlobeNewswire)
Apr-04-24 11:33AM	Aggressive Stock Portfolio: 13 Stocks Picked by Analysts (Insider Monkey)
08:00AM	Loading…
Apr-02-24 08:00AM	Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-14-24 08:23AM	Pacira's (PCRX) Knee Osteoarthritis Drug Gets FDA's RMAT Tag (Zacks)
Mar-13-24 07:00AM	Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee (GlobeNewswire)
Mar-08-24 11:55PM	Director Gary Pace Sells 119,323 Shares of Pacira BioSciences Inc (PCRX) (GuruFocus.com)
Mar-06-24 08:00AM	Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference (GlobeNewswire)
Mar-04-24 08:28PM	11 Best Small Cap Pharma Stocks to Invest In (Insider Monkey)
Mar-01-24 08:38AM	Pacira BioSciences, Inc. (NASDAQ:PCRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:05AM	Pacira (PCRX) Q4 Earnings Match, Exparel Sales Drive Revenues (Zacks)
12:28AM	Q4 2023 Pacira Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-29-24 10:00AM	Here's What Key Metrics Tell Us About Pacira (PCRX) Q4 Earnings (Zacks)
09:15AM	Pacira (PCRX) Matches Q4 Earnings Estimates (Zacks)
08:32AM	Pacira BioSciences Inc (PCRX) Reports Record Revenues and Robust Earnings for Full-Year 2023 (GuruFocus.com)
08:26AM	Pacira: Q4 Earnings Snapshot (Associated Press Finance)
08:00AM	Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results (GlobeNewswire)
Feb-22-24 08:00AM	Pacira to Report 2023 Financial Results on Thursday February 29, 2024 (GlobeNewswire)
08:36AM	Loading…
Feb-15-24 08:36AM	Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy (GlobeNewswire)
Feb-07-24 08:00AM	Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc. (GlobeNewswire) -7.44%
Feb-01-24 10:45AM	G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball Teams (PR Newswire)
Jan-05-24 12:21PM	Pacira (PCRX) Preliminary '23 Revenues Solid, Exparel Strong (Zacks) +5.71%
Jan-04-24 05:00PM	Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues (GlobeNewswire)
Jan-03-24 08:00AM	Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-21-23 07:30AM	Pacira Appoints Frank D. Lee as Chief Executive Officer (GlobeNewswire)
Dec-06-23 11:13AM	Hedge Funds are Betting on These 14 Sliding Stocks (Insider Monkey)
Nov-13-23 10:10AM	Pacira (PCRX) Gets FDA Nod for Exparel's Label Expansion (Zacks)
Nov-10-23 07:30AM	Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications (GlobeNewswire)
Nov-07-23 08:00AM	Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November (GlobeNewswire)
Nov-04-23 10:28AM	Pacira BioSciences, Inc. (NASDAQ:PCRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-02-23 12:34PM	Pacira (PCRX) Q3 Earnings and Revenues Miss, '23 View Updated (Zacks)
10:00AM	Pacira BioSciences Inc (PCRX) Reports Q3 2023 Financial Results (GuruFocus.com)
08:23AM	Pacira: Q3 Earnings Snapshot (Associated Press Finance)
08:00AM	Pacira BioSciences Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-26-23 08:00AM	Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023 (GlobeNewswire)
Oct-12-23 08:00AM	American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc. (GlobeNewswire)
Oct-10-23 08:00AM	Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors (GlobeNewswire)
Oct-02-23 08:00AM	American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care (GlobeNewswire)
Sep-27-23 12:07PM	Unraveling the Future of Pacira BioSciences Inc (PCRX): A Deep Dive into Key Metrics (GuruFocus.com) -6.51%
11:50AM	Unveiling Pacira BioSciences (PCRX)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Sep-26-23 04:30PM	Pacira BioSciences Announces Leadership Succession Plan (GlobeNewswire)
Sep-06-23 08:00AM	Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-03-23 10:03AM	Qualcomm downgraded, Wingstop upgraded: Wall Street's top analyst calls (The Fly) +5.56%
Aug-02-23 12:45PM	Pacira (PCRX) Q2 Earnings and Sales Miss, '23 View Updated (Zacks)
08:11AM	Pacira: Q2 Earnings Snapshot (AP Finance)
08:00AM	Pacira BioSciences Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-28-23 02:56PM	10 Best Small Cap Pharma Stocks to Buy (Insider Monkey)
Jul-26-23 08:00AM	Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023 (GlobeNewswire)
Jun-21-23 08:00PM	PCRX: Raising target price to $42.00 (Argus Research)
Jun-02-23 11:31AM	Why Is Pacira (PCRX) Down 11.8% Since Last Earnings Report? (Zacks)
May-31-23 08:00AM	Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference (GlobeNewswire)
May-09-23 08:00AM	Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-03-23 11:42PM	Q1 2023 Pacira Biosciences Inc Earnings Call (Thomson Reuters StreetEvents) -7.17%
05:25PM	Why Pacira BioSciences Shares Are Trading Lower Today (Benzinga)
03:11PM	Pacira (PCRX) Q1 Earnings Miss Estimates, Revenues Beat (Zacks)
08:11AM	Pacira: Q1 Earnings Snapshot (AP Finance)
08:00AM	Pacira BioSciences Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-26-23 08:00PM	PCRX: Lowering target price to $35.00 (Argus Research)
08:00AM	Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023 (GlobeNewswire)
Apr-20-23 09:20AM	A Look At The Fair Value Of Pacira BioSciences, Inc. (NASDAQ:PCRX) (Simply Wall St.)
08:00AM	Pacira BioSciences Partners with The Invited Celebrity Classic a PGA TOUR Champions Event to Make iovera° The Official Non-Opioid Pain Management Partner (GlobeNewswire)
Apr-19-23 08:00AM	Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer (GlobeNewswire)
Apr-12-23 08:00AM	Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-03-23 08:00AM	Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources (GlobeNewswire)
Mar-30-23 11:30AM	Why Is Pacira (PCRX) Down 6% Since Last Earnings Report? (Zacks)
Mar-29-23 08:00AM	Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures (GlobeNewswire)
Mar-27-23 08:00AM	Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit (GlobeNewswire)
Mar-24-23 08:50AM	Pacira BioSciences (NASDAQ:PCRX) shareholders have lost 49% over 1 year, earnings decline likely the culprit (Simply Wall St.)
Mar-22-23 08:00AM	Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors (GlobeNewswire)
Mar-09-23 09:17AM	Pacira BioSciences, Inc. (NASDAQ:PCRX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-08-23 08:00AM	Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference (GlobeNewswire)
Feb-28-23 11:39PM	Q4 2022 Pacira Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
08:00AM	Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results (GlobeNewswire)
Feb-23-23 08:00AM	LPGA, Pacira BioSciences Partner to Raise Awareness of Non-Opioid Pain Management Solutions (GlobeNewswire)
Feb-21-23 08:00AM	Pacira to Report 2022 Financial Results on Tuesday February 28, 2023 (GlobeNewswire)
Jan-05-23 04:30PM	Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million (GlobeNewswire)
Jan-04-23 08:00AM	Pacira BioSciences to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-20-22 10:06AM	Pacira BioSciences, Inc. (NASDAQ:PCRX) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? (Simply Wall St.)
Dec-13-22 08:00AM	Pacira BioSciences Reports Preliminary Net Product Sales of $57.5 Million for November 2022 (GlobeNewswire) -6.64%
Nov-18-22 01:38PM	Will Pacira's (PCRX) Exparel Aid Growth Amid High Reliance? (Zacks)
Nov-17-22 08:05AM	New Research Reveals Common Treatments for Knee Pain are Falling Short, Placing Physical, Social, and Mental Burden on Patients (PR Newswire)
Nov-14-22 08:00AM	Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2022 (GlobeNewswire)
Nov-09-22 05:14AM	Pacira BioSciences Third Quarter 2022 Earnings: EPS Misses Expectations (Simply Wall St.)
Nov-08-22 08:00AM	Pacira BioSciences to Present at Two Healthcare Conferences in November (GlobeNewswire)
Nov-04-22 10:54AM	Pacira's (PCRX) Q3 Earnings Miss Estimates, Revenues Beat (Zacks)
Nov-03-22 09:15AM	Pacira (PCRX) Lags Q3 Earnings Estimates (Zacks)
08:00AM	Pacira BioSciences Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-01-22 10:01AM	VAXART, INC. (VXRT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients' journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PACE GARY W	Director	Mar 08 '24	Sale	30.60	90,000	2,754,000	22,127	Mar 08 05:33 PM
PACE GARY W	Director	Mar 07 '24	Sale	30.81	28,257	870,598	112,127	Mar 08 05:33 PM
PACE GARY W	Director	Mar 06 '24	Sale	29.67	1,066	31,628	140,384	Mar 08 05:33 PM
WINSTON ROY	Chief Medical Officer	Aug 02 '23	Sale	34.88	509	17,751	52,440	Aug 04 04:47 PM
Riker Lauren Bullaro	Senior Vice President, Finance	Jul 05 '23	Sale	38.91	643	25,019	22,687	Jul 07 08:04 PM
Riker Lauren Bullaro	Senior Vice President, Finance	Jun 14 '23	Sale	38.42	6,366	244,606	22,687	Jun 16 05:39 PM
Williams Kristen Marie	Chief Administrative Officer	Jun 14 '23	Sale	37.03	6,467	239,473	25,375	Jun 16 05:42 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PCRX

Pacira BioSciences Inc

Upgrade your FINVIZ experience